Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs dexmedetomidine for postoperative delirium in staged bilateral total knee replacement
KCT0008227Phase 4Not yet recruiting
- Sponsor
- Jeonbuk National University Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midazolam, dexmedetomidine in postoperative delirium (POD), sponsored by Jeonbuk National University Hospital. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
midazolamdexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on KCT0008227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008227.